Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

45.80p
   
  • Change Today:
    -0.20p
  • 52 Week High: 49.55p
  • 52 Week Low: 29.35p
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 680,444
  • Market Cap: £247.58m
  • RiskGrade: 119
  • Beta: 0.00

Alliance Pharma to delay release of 2023 results

By Benjamin Chiou

Date: Friday 05 Apr 2024

LONDON (ShareCast) - (Sharecast News) - Shares in Alliance Pharma slipped on Friday after the healthcare company said that its full-year results would be delayed.
Alliance, which had been due to publish its preliminary results for 2023 on 9 April, said figures are now expected to be released on 23 April.

"The group's auditor has determined that the volume of work required to complete the audit has exceeded its original expectations, necessitating a short delay in the reporting timetable," the statement said.

Nevertheless, the company assured that details provided in its latest trading update in January "remain accurate".

Alliance has already reported revenues of £182.7m for 2023, up 6% on the previous year, while underlying profits were said to be in line with market expectations.

The stock was down 2% at 37.66p by 0803 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 45.80p
Change Today -0.20p
% Change -0.43 %
52 Week High 49.55p
52 Week Low 29.35p
Volume 680,444
Shares Issued 540.57m
Market Cap £247.58m
Beta 0.00
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.55% below the market average11.55% below the market average11.55% below the market average11.55% below the market average11.55% below the market average
79.59% above the sector average79.59% above the sector average79.59% above the sector average79.59% above the sector average79.59% above the sector average
Price Trend
54.15% above the market average54.15% above the market average54.15% above the market average54.15% above the market average54.15% above the market average
75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average
Income Not Available
Growth
38.78% below the market average38.78% below the market average38.78% below the market average38.78% below the market average38.78% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 03-Jan-2025

Time Volume / Share Price
16:38 97,000 @ 46.09p
16:38 19,894 @ 45.80p
16:35 14,035 @ 45.80p
16:35 1 @ 45.80p
16:35 235 @ 45.80p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page